Bristol-Myers Squibb: Devens, Massachusetts
 
Devens, Massachusetts

Facts and Figures
  • Located 45 miles west of Boston, the 89-acre site accommodates a large-scale multi-product bulk biologics facility.
  • The site is made up of four main buildings: a BioPharma manufacturing facility, a central utility building, an administrative/quality control building and a warehouse/storage structure. There is also a waste water pretreatment plant
  • The site can accommodate potential future expansion. The facility supports the production of ORENCIA® (abatacept), the company's biologic therapy for rheumatoid arthritis.”
Economic Development
  • The capital investment for the Devens site was $750 million, the largest capital investment in BMS history. Construction of the Devens Site began in 2007 and was completed in 2009.
  • Over 1,000 contractors were employed at the peak of construction.
Community and Social Progress
  • In 2010, Bristol-Myers Squibb of Devens, MA achieved Platinum Level based on the employee blood donations during 2009. Platinum is the highest achievement in the American Red Cross Life Share Program and is awarded to sponsors with a participation rate of greater than 30 percent of their employee population.
  • The Bristol-Myers Squibb Community Outreach Committee is going on their fourth year of participation in the North Central MA Habitat for Humanity programs. Together they have helped build close to 8 homes for families in need.
  • Supported Ayer Public School System Science Program
  • Supported a local shelter than runs a housing facility for women with children in Devens, MA.
  • BMS Devens employees routinely donate their time at a food pantry that serves local communities by preparing and serving, on a monthly basis, dinners to local families in need
Environmental Performance
  • Bristol-Myers Squibb was awarded Leadership in Energy and Environmental Design (LEED) Gold certification for the laboratory / administration building and LEED Silver certification for the cell culture manufacturing facility. LEED is a highly structured certification program administered by U.S. Green Buildings Council (www.USGBC.org). Certification is based on many project design aspects, including site development, environmental impact, water and energy use, construction impact, and architectural and building materials.
  • The Devens site was awarded with an innovation award by the Massachusetts Toxic Use Reduction Institute (TURI) for a project that recycled 3.6 million gallons of clean and flush water associated with facility startup.
  • The site is an active partner with EcoStar, a local non-profit organization that works with companies to develop and enhance various environmental, health and safety operational practices.
  • The facility adopted the Blanding Turtle ("threatened" under the Massachusetts Endangered Species Act) as part of the company's Sustainability goals, which encourage each facility and business to help protect endangered species and habitats. To protect the turtles, Devens employees developed a partnership with the Commonwealth of Massachusetts Department of Fish and Game, the U.S. Fish & Wildlife service and local conservation groups.
  • Devens employees have partnered with local conservation groups by engaging in invasive plant removal in local streams and ponds, as well as by maintaining sections of local walking trails.

Key Facility Environmental Performance Metrics 2012
Total Energy Use 360,000 gigajoules
Water Use 269,000,000 liters

Facility Contact Information

978-784-6001

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.